The widespread study of renal tubular injury biomarkers including KIM-1, NGAL, IL-18 and L-FABP as potential biomarkers for acute and chronic kidney disease has resulted in concerns about the impact of sample handling, processing and storage conditions on biomarker levels. This evidence concerns the gene LCN2 and chronic kidney disease.